# The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease

> **NCT02252588** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 44 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Chlorhexidine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02252588
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-01
- **Primary completion:** 2019-12-15
- **Final completion:** 2020-01-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02252588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02252588, "The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02252588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*